Long-term survival and complete response to adriamycin and etoposide in a case of hepatocellular carcinoma.
Overview
abstract
Hepatocellular carcinoma has a poor prognosis and is poorly responsive to systemic chemotherapy. Here we describe a case with unresectable hepatocellular carcinoma who achieved a complete response and has survived for more than 2 years, following treatment with a combination of adriamycin and etoposide (VP 16-213).